Slovenian drug firm Krka's first-half sales rise 0.4 pct

Krka dd Novo Mesto

03/07/2014 13:56

LJUBLJANA, July 3 (Reuters) - Slovenian pharmaceutical 
company Krka  KRKG.LJ  posted sales of 599.4 million euros 
($817.6 million) in the first half of 2014, up 0.4 percent on 
the same period last year. 
    The biggest growth was in southeastern Europe where sales 
rose by 11 percent, it said in a statement on Thursday. 
    The company is due to report profit figures for the first 
six months of the year on July 24. 
    Shares in Krka, Slovenia's largest listed company, closed 
down 1.72 percent at 68.5 euros on Thursday, while the blue-chip 
SBI index  .SBITOP  lost 0.65 percent. 
 
    ($1 = 0.7331 Euros) 
 
 (Reporting By Marja Novak; Editing by Pravin Char) 
 ((Marja.Novak@thomsonreuters.com)(+386-8-205-6369)(Reuters 
Messaging: marja.novak.thomsonreuters.com@reuters.net)) 
 
Keywords: SLOVENIA KRKA/